This morning the FDA issued a statement on CCSVI treatment in the U.S., including requirements for clinical trials. The FDA welcomes patient input and has invited CCSVI Alliance to connect with them. CCSVI Alliance intends to continue its work to both support patients and advance research into CCSVI.